Reviva Pharmaceuticals
RVPH
RVPH
36 hedge funds and large institutions have $27.1M invested in Reviva Pharmaceuticals in 2023 Q4 according to their latest regulatory filings, with 16 funds opening new positions, 14 increasing their positions, 3 reducing their positions, and 3 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
7.12% more ownership
Funds ownership: 11.76% → 18.88% (+7.1%)
0% more call options, than puts
Call options by funds: $3.48M | Put options by funds: $3.48M
Holders
36
Holding in Top 10
–
Calls
$3.48M
Puts
$3.48M
Top Buyers
| 1 | +$5.99M | |
| 2 | +$1.95M | |
| 3 | +$1.85M | |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$1.06M |
| 5 |
PAMP
Polar Asset Management Partners
Toronto,
Ontario, Canada
|
+$797K |
Top Sellers
| 1 | -$631K | |
| 2 | -$342K | |
| 3 | -$238K | |
| 4 |
SM
Sabby Management
Miami Beach,
Florida
|
-$218K |
| 5 |
WAM
Wolverine Asset Management
Chicago,
Illinois
|
-$48.2K |